P2X7R of synovial fibroblasts is a potential therapeutic target associated with refractory rheumatoid arthritis
Science Advances · 22.05.2026 · 12 (21)
DOI: 10.1126/sciadv.adw9543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 22.05.2026. Verfasst von Peishi Rao und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory Non-invasive Diagnosis and Immunotherapy of R…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Receptors, Purinergic P2X7, Fibroblasts, Synovial Membrane. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing Nova Program, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovitis. Synovial fibroblasts (SF) are the predominant cellular components in the inflamed synovium. Recent studies have shown increased expression of P2X7 receptor (P2X7R) in RA SF. However, its precise expression patterns and its contribution to inflammatory arthritis remain unclear. We demonstrate that P2X7R is robustly expressed in RA synovium, correlating with increased synovitis and systemic inflammation. Single-cell transcriptome analysis indicated that P2X7R was enriched in specific SF associated with refractory RA. Then, we applied a highly selective human P2X7R antagonist, EVT-401, which promoted apoptosis and induced cell cycle arrest in RA SF, reduced the production of proinflammatory and joint-destructive mediators, and mitigated aggressive phenotypes. Furthermore, we demonstrated that EVT-401 markedly reduced synovial inflammation and arthritis severity in a nonhuman primate model of autoimmune arthritis. Together, these findings suggest that P2X7R is involved in synovial inflammation and its inhibition may represent a potential therapeutic strategy for refractory RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory Non-invasive Diagnosis and Immunotherapy of Rheumatic Diseases, Beijing, China.
- Department of Rheumatology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
- Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen, China.
- NHC Key Laboratory of Medical Immunology (Peking University), School of Basic Medical Sciences, Peking University, Beijing, China.
- Zhejiang Jinhua Conba Bio-Pharm. Co. Ltd., Jinhua, China.
- State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.
ORCID-Profile: Peishi Rao, Shanzhao Jin, Shibai Xiao, Yinchao Ma, Jing Li, Xuanlin Cai, Xiaocheng Wang, Shenjie Ma, Wenjuan Zhang, Ru Li, Liang Zhang, Qingping Jin, Qingwen Wang, Ming Chu, Xiaolin Sun, Zhanguo Li
Förderung
- National Natural Science Foundation of China
- Beijing Nova Program
- Basic and Applied Basic Research Foundation of Guangdong Province
- Natural Science Foundation of China
- Beijing Natural Science Foundation
- Shenzhen Medical Research Fund
- Zhejiang Jinhua Conba Bio-Pharm. Co.,Ltd
- Peking University People's Hospital Scientific Research Development Funds Project
Zitieren
APA
Rao, P., Jin, S., Xiao, S., Ma, Y., Li, J., Liao, Y., Wang, Z., Tang, Y., Cai, X., Zeng, X., Hong, Y., Wang, X., He, J., Ma, S., Jiang, J., Zhang, W., Zhang, B., Li, R., Zhang, L., …, & Li, Z. (2026). P2X7R of synovial fibroblasts is a potential therapeutic target associated with refractory rheumatoid arthritis. Science Advances, 12(21). https://doi.org/10.1126/sciadv.adw9543
Vancouver
Rao P, Jin S, Xiao S, Ma Y, Li J, Liao Y, et al. P2X7R of synovial fibroblasts is a potential therapeutic target associated with refractory rheumatoid arthritis. Science Advances. 2026;12(21). doi:10.1126/sciadv.adw9543
BibTeX
@article{Rao2026,
author = {Rao, Peishi and Jin, Shanzhao and Xiao, Shibai and Ma, Yinchao and Li, Jing and Liao, Yuhua and Wang, Ziye and Tang, Yundi and Cai, Xuanlin and Zeng, Xingyue and Hong, Yixiang and Wang, Xiaocheng and He, Jiaxin and Ma, Shenjie and Jiang, Junyi and Zhang, Wenjuan and Zhang, Baozhen and Li, Ru and Zhang, Liang and Xu, Chuanhui and Jin, Qingping and Wang, Qingwen and Chu, Ming and Sun, Xiaolin and Li, Zhanguo},
title = {P2X7R of synovial fibroblasts is a potential therapeutic target associated with refractory rheumatoid arthritis},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {21},
doi = {10.1126/sciadv.adw9543}
}
EUVIMED